Search Results 6701-6710 of 25438 for oral
recombinant human growth hormone [rhGH] insulin, oral beta adrenergic agonists, megestrol acetate, dronabinol, metformin or other drugs) which might ...
... oral study drug. Exclusion Criteria. Diagnosis of sleep apnea (OSA, CSA) that is not adequately controlled at the discretion of the Investigator. Diagnosis ...
Approved forms of contraception include hormonal intrauterine devices or hormonal contraceptives (oral birth control pills, Depo-Provera®, patch, or other ...
NOTE: PET-CT scans are allowed provided the CT portion of the exam is equivalent to a diagnostic CT scan and includes both oral and IV contrast. Patients ...
Oral Oncology Reports. 2025; 13:100695; Whaley RD, Gupta S, Manninen MC, O'Brien DR, Erickson LA. Clinicopathologic and Molecular Analysis of 15 Pediatric ...
... oral antispasticity, anticoagulant and/or anticholinergic medication if treated are considered by the investigator likely to remain stable for the duration ...
Active infection requiring oral or IV antimicrobials for management within 7 days of first dose tarlatamab. Exclusion of hepatitis infection based on the ...
Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch EP. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal ...
NOTE: patients must be off corticosteroids for at least 2 weeks prior to registration; this includes oral, IV, subcutaneous, or inhaled route of ...
- Able to swallow and retain oral medication with no clinically significant gastrointestinal abnormalities that may alter absorption, such as malabsorption ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.